论文部分内容阅读
目的探讨坦索罗辛对肾结石体外冲击波碎石(ESWL)术后排石的疗效及对并发症的预防作用。方法120例单纯肾结石行ESWL术患者,结石直径8-22 mm,随机分成2组,坦索罗辛组60例,给予氟罗沙星、排石冲剂及坦索罗辛(哈乐),对照组60例,给予氟罗沙星、排石冲剂,治疗时间4周,比较2组之间结石排净率、石街的形成、疼痛评分(VAS)、膀胱刺激症状。结果坦索罗辛组的结石排净率(88.3%)高于对照组(71.7%)(P=0.022),坦索罗辛组石街形成率(6.7%)低于对照组(16.7%)(P=0.040),坦索罗辛组疼痛VAS评分[2(0-7)分]低于对照组[4(0-8)分(P<0.01)],坦索罗辛组膀胱刺激症状发生率(10%)低于对照组(21.7%)(P=0.024)。治疗期间2组未出现药物不良反应。结论ESWL术后坦索罗辛能够促进ESWL术后结石排出,预防石街形成,缓解疼痛及膀胱刺激症状,可以作为肾结石ESWL术后排石的辅助用药。
Objective To investigate the effect of tamsulosin on the prevention of postoperative stone failure after ESWL and the preventive effect on the complications. Methods One hundred and twenty patients with simple nephrolithiasis ESWL were randomly divided into 2 groups, with tamsulosin group (n = 60). The patients were treated with fleroxacin, Paishi granule and tamsulosin Sixty patients were treated with fleroxacin and quetiapine granules. The treatment time was 4 weeks. The stone clearance rate, stone street formation, pain score (VAS) and bladder irritation were compared between the two groups. Results The tamsulosin group had a higher stone clearance rate (88.3%) than the control group (71.7%) (P = 0.022), the tamsulosin stone street formation rate (6.7%) was lower than the control group (16.7% (P = 0.040), tamsulosin group pain VAS score [2 (0-7) points) was lower than the control group [4 (0-8) points The incidence (10%) was lower than that in the control group (21.7%) (P = 0.024). There were no adverse drug reactions in the two groups during the treatment. Conclusion Tamsulosin after ESWL can promote stone discharge after ESWL, prevent stone street formation, relieve pain and irritation of bladder. It can be used as adjuvant for stone row after ESWL.